Storia in 20 fonti

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

US drugmakers Merck and Moderna said Wednesday a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough."

Raccontata da

fortune.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

france24.comStai leggendo16 h fa

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

originale

Timeline cronologica

mercoledì 19 agosto 2026·biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…
mercoledì 19 agosto 2026·healio.com
mRNA melanoma vaccine-pembrolizumab combo shows survival gains in late-stage trial
A phase 3 trial found that a combination of intismeran autogene plus pembrolizumab improved recurrence-free and distant metastasis-free survival in patients with high-risk…

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Confronto fonti

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Timeline cronologica

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

mRNA melanoma vaccine-pembrolizumab combo shows survival gains in late-stage trial

‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial

‘First time’: Drug giants’ cancer breakthrough

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in…

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

Moderna shares double after experimental mRNA cancer treatment passes key test

A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

Moderna y Merck anuncian el éxito de la primera vacuna personalizada contra el melanoma y sus acciones se disparan en Bolsa

Successo del farmaco antimelanoma, Moderna strappa a Wall Street

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

Il vaccino mRNA contro il melanoma funziona: Moderna vola in Borsa

‘First time’: Drug giants’ cancer breakthrough

Melanoma, nuove speranze da vaccino sperimentale di Moderna e Merck: "Risultati promettenti" - Il Quotidiano del Sud

Moderna y Merck se disparan en Wall Street tras resultados prometedores de vacuna contra cáncer de piel - EFE

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

Moderna und Merck: Krebsimpfstoff Intismeran besteht Phase 3 – Aktien steigen massiv

Moderna: Erfolgreiche Studie zu Hautkrebs-Impfstoff beflügelt Börsenkurs

Melanoma, risultati positivi per il vaccino a mRna (la stessa tecnologia usata contro il Covid) personalizzato

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Moderna and Merck shares soar on mRNA cancer vaccine

New Cancer Treatment Hope After mRNA Vaccine Success

Moderna y Merck anuncian el éxito de su vacuna contra el melanoma tras un ensayo con resultados prometedores

Il vaccino contro il melanoma fa volare il titolo di Moderna a Wall Street: come funziona e quando sarà disponibile